All lobbying filings

LMH Strategic Solutions

LMH Strategic Solutions filed a Q4 report for PTC Therapeutics, Inc. on January 12, 2026, reporting $50,000 in lobbying income.

Lobbying for PTC Therapeutics, Inc. · Biopharmaceutical company.

As filed: LMH STRATEGIC SOLUTIONS for PTC THERAPEUTICS, INC.

All filings by LMH Strategic Solutions · Everything PTC Therapeutics, Inc. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 12, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Lobbyists on this filing 1

ALANNA TEMME

Previously held: Legislative Director, U.S. Representative Jon Porter

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to access to rare disease therapies, diagnosis and testing. Issues related to FDA modernization and rare disease drug development. Issues related to Public Law No. 117-169 - The Inflation Reduction Act of 2022. Issues related to alternative funding programs. Issues related to the Rare Pediatric Disease Priority Review Voucher program, including H.R.1262/S.932 - Give Kids a Chance Act of 2025.

Bills named in this filing 2

H.R. 1262
Mikaela Naylon Give Kids a Chance Act
S. 932
Give Kids a Chance Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.